The FDA published proposed guidelines covering fecal transplants that require donated stool be obtained from a donor that is known to either the patient or the licensed health care provider treating the patient. That could pose a problem for the new OpenBiome stool bank at MIT, which keeps its donors anonymous. The FDA is seeking public comments about the proposed guidelines, which would govern the procedure that treats recurrent diarrhea caused by Clostridium difficile bacteria.

Full Story:
WBUR-FM (Boston)

Related Summaries